Skip to search formSkip to main contentSkip to account menu

fluoroazomycin arabinoside

Known as: fluoroazomycinarabinoside 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

18F-FAZA

Broader (1)

Nitroimidazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OA09.05 Positron Emission Tomography (PET) with 18F-Fluoroazomycin Arabinoside (FAZA) to Assess Tumor Hypoxia in Non-Small Cell Lung Cancer (NSCLC)
Review
2014
Review
2014
[Nuclear Medicine in diagnosis of breast cancer].
Breast cancer is the most common malignancy among women worldwide, creating a significant need for improved imaging modalities… 
Review
2014
Review
2014
Functional and molecular imaging in cancer drug development.
Imaging biomarkers have a potential to identify key metabolic pathways that are up-regulated in cancer cells compared to normal… 
2011
2011
Quantification in dynamic and small-animal positron emission tomography
This thesis covers two aspects of positron emission tomography (PET) quantification. The first section addresses the… 
2011
2011
808 Poster 18f- FLUOROAZOMYCIN ARABINOSIDE (FAZA) PET IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)
2010
2010
Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET
Abstract Positron emission tomography (PET) allows non-invasive detection and mapping of tumor hypoxia. However, slow tracer… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)